A citation-based method for searching scientific literature

Veronika Götz, Linda Magar, Dominik Dornfeld, Sebastian Giese, Anne Pohlmann, Dirk Höper, Byung-Whi Kong, David A Jans, Martin Beer, Otto Haller, Martin Schwemmle. Sci Rep 2016
Times Cited: 84







List of co-cited articles
1146 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Leon Caly, Julian D Druce, Mike G Catton, David A Jans, Kylie M Wagstaff. Antiviral Res 2020
737
53

Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus.
Kylie M Wagstaff, Haran Sivakumaran, Steven M Heaton, David Harrich, David A Jans. Biochem J 2012
322
51

Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin.
M Y F Tay, J E Fraser, W K K Chan, N J Moreland, A P Rathore, C Wang, S G Vasudevan, D A Jans. Antiviral Res 2013
144
46

Corrigendum: Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import.
Veronika Götz, Linda Magar, Dominik Dornfeld, Sebastian Giese, Anne Pohlmann, Dirk Höper, Byung-Whi Kong, David A Jans, Martin Beer, Otto Haller,[...]. Sci Rep 2016
41
87

Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication.
Lindsay Lundberg, Chelsea Pinkham, Alan Baer, Moushimi Amaya, Aarthi Narayanan, Kylie M Wagstaff, David A Jans, Kylene Kehn-Hall. Antiviral Res 2013
84
35

The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer.
Sundy N Y Yang, Sarah C Atkinson, Chunxiao Wang, Alexander Lee, Marie A Bogoyevitch, Natalie A Borg, David A Jans. Antiviral Res 2020
109
35

The pharmacokinetics and interactions of ivermectin in humans--a mini-review.
Aránzazu González Canga, Ana M Sahagún Prieto, M José Diez Liébana, Nélida Fernández Martínez, Matilde Sierra Vega, Juan J García Vieitez. AAPS J 2008
136
25

Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.
Eloise Mastrangelo, Margherita Pezzullo, Tine De Burghgraeve, Suzanne Kaptein, Boris Pastorino, Kai Dallmeier, Xavier de Lamballerie, Johan Neyts, Alicia M Hanson, David N Frick,[...]. J Antimicrob Chemother 2012
195
25

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Bin Cao, Yeming Wang, Danning Wen, Wen Liu, Jingli Wang, Guohui Fan, Lianguo Ruan, Bin Song, Yanping Cai, Ming Wei,[...]. N Engl J Med 2020
25

Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein.
Benjamin Mänz, Dominik Dornfeld, Veronika Götz, Roland Zell, Petra Zimmermann, Otto Haller, Georg Kochs, Martin Schwemmle. PLoS Pathog 2013
107
23

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Manli Wang, Ruiyuan Cao, Leike Zhang, Xinglou Yang, Jia Liu, Mingyue Xu, Zhengli Shi, Zhihong Hu, Wu Zhong, Gengfu Xiao. Cell Res 2020
23

An AlphaScreen®-based assay for high-throughput screening for specific inhibitors of nuclear import.
Kylie M Wagstaff, Stephen M Rawlinson, Anna C Hearps, David A Jans. J Biomol Screen 2011
89
22

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Philippe Gautret, Jean-Christophe Lagier, Philippe Parola, Van Thuan Hoang, Line Meddeb, Morgane Mailhe, Barbara Doudier, Johan Courjon, Valérie Giordanengo, Vera Esteves Vieira,[...]. Int J Antimicrob Agents 2020
22

The viral nucleoprotein determines Mx sensitivity of influenza A viruses.
Petra Zimmermann, Benjamin Mänz, Otto Haller, Martin Schwemmle, Georg Kochs. J Virol 2011
123
20

Inhibitors of nuclear transport.
David A Jans, Alexander J Martin, Kylie M Wagstaff. Curr Opin Cell Biol 2019
51
31

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Xueting Yao, Fei Ye, Miao Zhang, Cheng Cui, Baoying Huang, Peihua Niu, Xu Liu, Li Zhao, Erdan Dong, Chunli Song,[...]. Clin Infect Dis 2020
19

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
19


Mx GTPases: dynamin-like antiviral machines of innate immunity.
Otto Haller, Peter Staeheli, Martin Schwemmle, Georg Kochs. Trends Microbiol 2015
232
16

Nuclear trafficking of proteins from RNA viruses: potential target for antivirals?
Leon Caly, Kylie M Wagstaff, David A Jans. Antiviral Res 2012
55
25

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
16

Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study.
Juliana Cepelowicz Rajter, Michael S Sherman, Naaz Fatteh, Fabio Vogel, Jamie Sacks, Jean-Jacques Rajter. Chest 2021
81
17


Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo.
Changjie Lv, Wenkai Liu, Bin Wang, Ruyi Dang, Li Qiu, Juan Ren, Chuanqi Yan, Zengqi Yang, Xinglong Wang. Antiviral Res 2018
41
31

Compassionate Use of Remdesivir for Patients with Severe Covid-19.
Jonathan Grein, Norio Ohmagari, Daniel Shin, George Diaz, Erika Asperges, Antonella Castagna, Torsten Feldt, Gary Green, Margaret L Green, François-Xavier Lescure,[...]. N Engl J Med 2020
15

First Case of 2019 Novel Coronavirus in the United States.
Michelle L Holshue, Chas DeBolt, Scott Lindquist, Kathy H Lofy, John Wiesman, Hollianne Bruce, Christopher Spitters, Keith Ericson, Sara Wilkerson, Ahmet Tural,[...]. N Engl J Med 2020
15

The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.
David Riegger, Rong Hai, Dominik Dornfeld, Benjamin Mänz, Victor Leyva-Grado, Maria T Sánchez-Aparicio, Randy A Albrecht, Peter Palese, Otto Haller, Martin Schwemmle,[...]. J Virol 2015
35
34

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Timothy P Sheahan, Amy C Sims, Rachel L Graham, Vineet D Menachery, Lisa E Gralinski, James B Case, Sarah R Leist, Krzysztof Pyrc, Joy Y Feng, Iva Trantcheva,[...]. Sci Transl Med 2017
762
14

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.
Travis K Warren, Robert Jordan, Michael K Lo, Adrian S Ray, Richard L Mackman, Veronica Soloveva, Dustin Siegel, Michel Perron, Roy Bannister, Hon C Hui,[...]. Nature 2016
692
14

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study.
Qingxian Cai, Minghui Yang, Dongjing Liu, Jun Chen, Dan Shu, Junxia Xia, Xuejiao Liao, Yuanbo Gu, Qiue Cai, Yang Yang,[...]. Engineering (Beijing) 2020
518
14

Remdesivir for the Treatment of Covid-19 - Final Report.
John H Beigel, Kay M Tomashek, Lori E Dodd, Aneesh K Mehta, Barry S Zingman, Andre C Kalil, Elizabeth Hohmann, Helen Y Chu, Annie Luetkemeyer, Susan Kline,[...]. N Engl J Med 2020
14

In vivo evasion of MxA by avian influenza viruses requires human signature in the viral nucleoprotein.
Christoph M Deeg, Ebrahim Hassan, Pascal Mutz, Lara Rheinemann, Veronika Götz, Linda Magar, Mirjam Schilling, Carsten Kallfass, Cindy Nürnberger, Sébastien Soubies,[...]. J Exp Med 2017
31
35

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
Timothy P Sheahan, Amy C Sims, Sarah R Leist, Alexandra Schäfer, John Won, Ariane J Brown, Stephanie A Montgomery, Alison Hogg, Darius Babusis, Michael O Clarke,[...]. Nat Commun 2020
812
13

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
Maria L Agostini, Erica L Andres, Amy C Sims, Rachel L Graham, Timothy P Sheahan, Xiaotao Lu, Everett Clinton Smith, James Brett Case, Joy Y Feng, Robert Jordan,[...]. mBio 2018
692
13

Dexamethasone in Hospitalized Patients with Covid-19.
Peter Horby, Wei Shen Lim, Jonathan R Emberson, Marion Mafham, Jennifer L Bell, Louise Linsell, Natalie Staplin, Christopher Brightling, Andrew Ustianowski, Einas Elmahi,[...]. N Engl J Med 2021
13

Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase.
Jan Dittmann, Silke Stertz, Daniel Grimm, John Steel, Adolfo García-Sastre, Otto Haller, Georg Kochs. J Virol 2008
108
11

Deep mutational scanning identifies sites in influenza nucleoprotein that affect viral inhibition by MxA.
Orr Ashenberg, Jai Padmakumar, Michael B Doud, Jesse D Bloom. PLoS Pathog 2017
33
30

The importin α/β-specific inhibitor Ivermectin affects HIF-dependent hypoxia response pathways.
Friederike K Kosyna, Marie Nagel, Larissa Kluxen, Kim Kraushaar, Reinhard Depping. Biol Chem 2015
28
35

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Nanshan Chen, Min Zhou, Xuan Dong, Jieming Qu, Fengyun Gong, Yang Han, Yang Qiu, Jingli Wang, Ying Liu, Yuan Wei,[...]. Lancet 2020
11

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro.
Ka-Tim Choy, Alvina Yin-Lam Wong, Prathanporn Kaewpreedee, Sin Fun Sia, Dongdong Chen, Kenrie Pui Yan Hui, Daniel Ka Wing Chu, Michael Chi Wai Chan, Peter Pak-Hang Cheung, Xuhui Huang,[...]. Antiviral Res 2020
392
11

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.
Martin J Vincent, Eric Bergeron, Suzanne Benjannet, Bobbie R Erickson, Pierre E Rollin, Thomas G Ksiazek, Nabil G Seidah, Stuart T Nichol. Virol J 2005
936
11

At the centre: influenza A virus ribonucleoproteins.
Amie J Eisfeld, Gabriele Neumann, Yoshihiro Kawaoka. Nat Rev Microbiol 2015
205
10

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.
Yousuke Furuta, Takashi Komeno, Takaaki Nakamura. Proc Jpn Acad Ser B Phys Biol Sci 2017
389
10

A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection.
Nicholas J Barrows, Rafael K Campos, Steven T Powell, K Reddisiva Prasanth, Geraldine Schott-Lerner, Ruben Soto-Acosta, Gaddiel Galarza-Muñoz, Erica L McGrath, Rheanna Urrabaz-Garza, Junling Gao,[...]. Cell Host Microbe 2016
274
10


Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA viruses.
Wahyu N Wulan, Deborah Heydet, Erin J Walker, Michelle E Gahan, Reena Ghildyal. Front Microbiol 2015
41
21

Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset.
Jasper Fuk-Woo Chan, Yanfeng Yao, Man-Lung Yeung, Wei Deng, Linlin Bao, Lilong Jia, Fengdi Li, Chong Xiao, Hong Gao, Pin Yu,[...]. J Infect Dis 2015
408
10

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.
Daniel Wrapp, Nianshuang Wang, Kizzmekia S Corbett, Jory A Goldsmith, Ching-Lin Hsieh, Olubukola Abiona, Barney S Graham, Jason S McLellan. Science 2020
10

Ivermectin, 'wonder drug' from Japan: the human use perspective.
Andy Crump, Satoshi Ōmura. Proc Jpn Acad Ser B Phys Biol Sci 2011
118
10

Coronaviruses: an overview of their replication and pathogenesis.
Anthony R Fehr, Stanley Perlman. Methods Mol Biol 2015
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.